UBS Group’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,426
| Closed | -$55.7K | – | 8999 |
|
|
2023
Q2 | $55.7K | Buy |
5,426
+2,753
| +103% | +$28.2K | ﹤0.01% | 5348 |
|
|
2023
Q1 | $27.1K | Buy |
2,673
+1,897
| +244% | +$19.2K | ﹤0.01% | 5772 |
|
|
2022
Q4 | $7.68K | Buy |
776
+600
| +341% | +$5.94K | ﹤0.01% | 7678 |
|
|
2022
Q3 | $2K | Hold |
176
| – | – | ﹤0.01% | 8742 |
|
|
2022
Q2 | $2K | Hold |
176
| – | – | ﹤0.01% | 8661 |
|
|
2022
Q1 | $2K | Hold |
176
| – | – | ﹤0.01% | 8683 |
|
|
2021
Q4 | $2K | Buy |
+176
| New | +$2K | ﹤0.01% | 8749 |
|